This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Columbia University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Madalee M. Gassaway
Introduction: Madalee M. Gassaway is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmacology, particularly in the development of mu-opioid receptor agonists. Her work is crucial in advancing therapeutic options for pain management.
Latest Patents: Madalee holds a patent for a class of mu-opioid receptor agonists. The present invention provides a compound having a specific structure or a pharmaceutically acceptable salt or ester thereof. This innovation is a testament to her expertise and dedication to improving medical treatments.
Career Highlights: Madalee is affiliated with Columbia University, where she engages in cutting-edge research. Her role at the university allows her to collaborate with other leading scientists and contribute to groundbreaking studies in her field.
Collaborations: Among her notable coworkers are Andrew Carry Kruegel and Adam Henke. Their collective efforts enhance the research environment and foster innovative solutions in pharmacology.
Conclusion: Madalee M. Gassaway's work exemplifies the impact of innovative thinking in the medical field. Her contributions to mu-opioid receptor agonists are paving the way for advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile